Olema Oncology – Investigational Compound for ER+ / HER2- Breast Cancer
Sean Bohen, M.D., Ph.D., is President and CEO of Olema Oncology, a company committed to improving outcomes for women living with cancer.
893 articles
Sean Bohen, M.D., Ph.D., is President and CEO of Olema Oncology, a company committed to improving outcomes for women living with cancer.
For 150 years, dentists have used amalgam fillings to fill and repair cavity-stricken teeth, but a newly released study indicates those fillings – whi
is the Chief Growth Officer at M2GEN, an oncology-focused health informatics solutions company with the mission to help patients get access to the best ...
Sarah Ringold, MD, MS, Director of Clinical Research in Pediatric Immunology at The Janssen Pharmaceutical Companies of Johnson & Johnson discusses the ...
Maria Ryan, DDS, PhD, Vice President and Chief Clinical Officer at the Colgate-Palmolive Company discusses the link between oral health, heart diseas...
Shannon Westin, MD, MPH, FACOG, gynecologic oncology physician at Lyndon Baines Johnson Hospital and a Professor in the Department of Gynecologic Oncolo...
Sara Koenig, Ph.D., assistant professor of physiology and cell biology at The Ohio State University College of Medicine, discusses a discovery of rare g...
Nadim Ahmed, President and CEO of Cullinan Oncology, a clinical-stage biotechnology company developing a diversified pipeline of potential first - and best-in-class targeted therapies for...
Stephen Williams, Chief Medical Officer at SomaLogic, a global leader in proteomics (the study of proteins), discusses what proteomics is, how it is use...
Neurology, Epilepsy and Rare Syndrome Portfolio at UCB, a global biopharma company, discusses the launch of partnerships with Le Bonheur Children’s Ho...